Loading company financials…
NEW YORK STOCK EXCHANGE, INC. · Chemicals · CIK 0001257640
$7.64
+2.14% · delayed ~15 min
Last price from Oct 22, 2026
$878.6M market value
From KRONOS WORLDWIDE INC's FY2025 10-K, filed Mar 9, 2026 · read the filing
KRONOS WORLDWIDE makes industrial chemicals. It took in $1.86B last year, which makes it a mid-sized company. It spends more than it earns — losing about 6 cents on every dollar of sales.
The filing does not provide enough evidence for a clear financial conclusion.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
A published bankruptcy-risk model places it in its distress range. This is a statistical reading, not a forecast.
Altman Z-Score 1.60
These are things the company filed or that a published model flagged — not predictions, and not a reason on their own to buy or sell anything.
Financial health
Significant financial weakness across most measures.
From KRONOS WORLDWIDE INC's FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Gross profit
$359.3M → $213.0M
Operating income
$122.9M → -$36.5M
Profit
$86.2M → -$110.9M
Operating margin
6.5% → -2.0%
Measured against FY2024, from the 10-K filed Mar 9, 2026
Deteriorated: -40.7%
$359.3M to $213.0MCritical
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Deteriorated: turned negative
$122.9M to -$36.5MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
How the latest move compares (quote delayed ~15 min), and what was published around it
KRO rose 2.14% on the latest quote. The average Materials company tracked here moved −1.23%, and the S&P 500 −1.04%. That is 3.4 points above its sector and 3.2 points above the market.
No filing from KRO and no news item about it appeared in the last 3 days.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Opinions from 9 analysts covering this company, as of . Their views, not this site's.
Of 9 analysts publishing on this company, 1 say buy, 2 say hold, 5 say sell and 1 say strong sell. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
The essentials
Each answered from the filings, with the numbers behind it.
No. It lost $110.9M last year, losing about 6 cents on every dollar of sales.
No. Sales shrank 1.5% last year.
Yes. Clearing its debt would take roughly 209.7 years of cash flow. For every $1 it owes, it owns $1.70 in assets. Its operating profit does not cover its interest bill — -0.69x against the interest it owes. A bankruptcy-risk model also places it in its distress range.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It paid a dividend while making a loss, so the payment did not come out of profits — it came from reserves, borrowing or asset sales. It paid out 920% of the cash its operations generated. It has paid in each of the last 12 years.
WeakFigures from the FY2025 annual filing
Last year it lost $110.9M and generated $2.5M of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Mar 9, 2026Filing for FY2025 | FY202410-K · Mar 6, 2025Filing for FY2024 | FY202310-K · Mar 6, 2025Filing for FY2023 | FY202210-K · Mar 6, 2024Filing for FY2022 | FY202110-K · Mar 9, 2022Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $1.86B | $1.89B | $1.67B | $1.93B | $1.94B | −1.5% |
| Cost of revenue | $1.65B | $1.53B | $1.50B | $1.54B | $1.49B | +7.8% |
| Gross profit | $213.0M | $359.3M | $164.9M | $391.1M | $446.2M | −40.7% |
| Gross marginGross profit ÷ revenueWhat is this? | 11.5% | 19.0% | 9.9% | 20.3% | 23.0% | −7.6 pts |
| Selling, general and administrative | $245.2M | $225.6M | $211.2M | $231.3M | $248.9M | +8.7% |
| Operating income | -$36.5M | $122.9M | -$56.0M | $159.6M | $187.1M | n/m |
| Operating marginOperating income ÷ revenueWhat is this? | -2.0% | 6.5% | -3.4% | 8.3% | 9.6% | −8.5 pts |
| Interest expense | $53.0M | $42.9M | $17.1M | $16.9M | $19.6M | +23.5% |
| Income before tax | -$97.4M | $149.6M | -$72.9M | $133.9M | $153.4M | n/m |
| Net income | -$110.9M | $86.2M | -$49.1M | $104.5M | $112.9M | n/m |
| Net marginNet income ÷ revenueWhat is this? | -6.0% | 4.6% | -2.9% | 5.4% | 5.8% | −10.5 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $-0.9643 | $0.7496 | $-0.427 | $0.9079 | $0.9775 | n/m |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| KROKRONOS WORLDWIDE INC · this page | 2.0/10 | 5/9 | -1.5% | -6.0% | — | 1.42x |
| DOW |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Nothing recent
No insider trades, pending-sale notices or 5% stake filings from KRO in the last few months. That is the ordinary case, not a gap.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Published results · Made a Regulation FD disclosure
Read the filingQuarterly report for Q2 FY2026
Revenue +12.9% · Operating margin +5.2 pts · Gross profit +63.7% — against Q2 FY2025
Read the filingWrite down why you are following KRONOS WORLDWIDE INC, what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 14 subsidiaries named in its 10-K. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from KRO's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Mar 9, 2026), reported under the US GAAP taxonomy. View the source filing. Total liabilities were not tagged directly and were calculated as assets minus equity.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 9 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 2.0 | 5/9 | 10-K, filed Mar 9, 2026 |
| FY2024 | 7.0 | 7/9 | 10-K, filed Mar 6, 2025 |
| FY2023 | 3.0 | 3/9 | 10-K, filed Mar 6, 2024 |
| FY2022 | 7.0 | 5/9 | 10-K, filed Mar 8, 2023 |
| FY2021 | 9.0 | 8/9 | 10-K, filed Mar 9, 2022 |
| FY2020 | 7.0 | 5/9 | 10-K, filed Mar 10, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
5 of 9 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's.
1.60
In the distress zone
For this model, above 2.99 is safe and below 1.81 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — This company has not reported enough of the required figures to calculate this score.
This company has not reported enough of the required figures to calculate this score.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Deteriorated: turned negative
$86.2M to -$110.9MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: −8.5 pts
6.5% to -2.0%Critical
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: −10.5 pts
4.6% to -6.0%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: turned negative
$43.0M to -$40.4MCritical
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Deteriorated: turned negative
$0.75 to -$0.96Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: -68.9%
$106.7M to $33.2MCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Changed: -58.3%
$55.2M to $23.0MCritical
Why it matters: Cash handed to shareholders. A rise can be a higher dividend or simply more shares, and a cut is a decision the company explains in its own filing — neither is rated here.
Changed: +45.4%
$29.5M to $42.9MCritical
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Deteriorated: −7.6 pts
19.0% to 11.5%Significant
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Deteriorated: +29.9%
$429.1M to $557.4MSignificant
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Aug 5, 2026 — read it.
Improved: +63.7%
$62.8M to $102.8MCritical
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: +408.1%
$7.4M to $37.6MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: turned positive
-$9.2M to $15.2MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: turned positive
-$0.08 to $0.13Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +40.7%
$18.9M to $26.6MCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +5.7 pts
12.7% to 18.4%Significant
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Improved: +5.2 pts
1.5% to 6.7%Significant
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +4.6 pts
-1.9% to 2.7%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: +12.9%
$494.4M to $558.1MNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Deteriorated: +13.6%
$501.4M to $569.6MNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Aug 5, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Improved: +198.4%
$12.6M to $37.6MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: turned positive
-$4.8M to $15.2MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: turned positive
-$0.04 to $0.13Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +23.4%
$83.3M to $102.8MSignificant
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: +4.3 pts
2.5% to 6.7%Significant
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +3.7 pts
-0.9% to 2.7%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: +9.5%
$509.8M to $558.1MNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +2.1 pts
16.3% to 18.4%Notable
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Improved: -5.5%
$602.7M to $569.6MNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
2 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 0.9% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
Trailing P/E is not meaningful because the latest trailing earnings are zero or negative. The price-to-book and price-to-sales figures below still provide reference points.
This company has not reported enough of the required figures to calculate this score.
| 4.0/10 |
| 4/9 |
| -7.0% |
| -6.1% |
| — |
| 2.66x |
| Median of peers | 4.0/10 | — | -7.0% | -6.1% | — | 2.66x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Held a shareholder vote · Made a Regulation FD disclosure
Published results
Read the filingQuarterly report for Q1 FY2026
Operating margin −5.4 pts · Operating income -67.2% · Profit turned negative — against Q1 FY2025
Read the filingProxy statement for a shareholder meeting
Read the filingPublished results
Read the filingAnnual report for FY2025
Operating margin −8.5 pts · Gross profit -40.7% · Operating income turned negative — against FY2024
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingPublished results
Read the filingQuarterly report for Q3 FY2025
Revenue -5.7% · Operating margin −12.2 pts · Gross profit -53.6% — against Q3 FY2024
Read the filingMade a Regulation FD disclosure
Read the filingSigned a material agreement · Took on a direct financial obligation
Read the filingMade a Regulation FD disclosure
Read the filingMade a Regulation FD disclosure
Read the filingHad a director or senior officer leave or join · Published results · Made a Regulation FD disclosure
Read the filingQuarterly report for Q2 FY2025
Operating margin −5.7 pts · Operating income -79.4% · Profit turned negative — against Q2 FY2024
Read the filingSigned a material agreement · Took on a direct financial obligation
Read the filingHad a director or senior officer leave or join · Held a shareholder vote · Made a Regulation FD disclosure
Read the filingPublished results
Read the filingSource: Exhibit 21 of the 10-K filed 2026-03-09. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Coverage from the last 30 days
Kronos Worldwide Shares Surge 72% YTD: What's Driving the Rally?
Yahoo ·
Is Kronos Worldwide (KRO) Stock Outpacing Its Basic Materials Peers This Year?
Yahoo ·
The Zacks Analyst Blog Highlights Chime Financial, Marqeta and Kronos
Yahoo ·
3 Stocks With 100%+ Projected Q3 Earnings Growth to Buy Before Results
Yahoo ·
Nutrien to Indefinitely Shut Down Trinidad Nitrogen Operations
Yahoo ·
KWR Strengthens Capital Structure With Term Loan B Refinancing
Yahoo ·
Sherwin-Williams Expands Manufacturing Capacity at Statesville
Yahoo ·
NGVT Stock Rallies 31% in a Year: What's Driving the Upside?
Yahoo ·
Westlake to Close Cologne PVC Plant Amid Weak European Market
Yahoo ·
FMC Submits Rimisoxafen Regulatory Filing for Approval in Brazil
Yahoo ·
Westlake Royal Expands Distribution Partnership With BlueLinx
Yahoo ·
BASFY Launches Lower-Carbon Paper Coating Dispersions
Yahoo ·
Primary sources and further research